Title: Achondroplasia a Multidisciplinary Conversation on Comprehensive Care
Date: Thursday, September 14 from 6:00 – 7:00pm EST
Summary of Session:
Achondroplasia (Ach), the most common skeletal dysplasia with disproportionate short stature, is characterized by a number of medical, functional, and psychosocial challenges across the lifespan of an individual. Up until recently, the treatment of the developmental complications of Ach involved only symptomatic management, surgical intervention, and lifelong follow-up care. An improved understanding of the molecular pathways involved in Ach has resulted in the development of new and emerging targeted therapies for this condition. These novel agents aim to restore bone growth and prevent many of the medical conditions associated with Ach. In this virtual live symposium, an expert panel will address the complications associated with Ach, current care recommendations, strategies for coordination of care with specialists, and new and emerging therapies for Ach.
- Andrew Dauber, MD, MMSc, Chief of Endocrinology, Children’s National Hospital, Washington, DC
- Nadia Merchant, MD, Assistant Professor of Pediatrics, Division of Endocrinology and Diabetes, Children’s National Hospital, Washington, DC
- William G. Mackenzie, MD, FRCS(c), FAAOS, Chairman, Department of Orthopedic Surgery, Nemours Children’s Health, Wilmington, DE